226 related articles for article (PubMed ID: 28218748)
1. HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity.
Hategan A; Bianchet MA; Steiner J; Karnaukhova E; Masliah E; Fields A; Lee MH; Dickens AM; Haughey N; Dimitriadis EK; Nath A
Nat Struct Mol Biol; 2017 Apr; 24(4):379-386. PubMed ID: 28218748
[TBL] [Abstract][Full Text] [Related]
2. Identification and Nanomechanical Characterization of the HIV Tat-Amyloid β Peptide Multifibrillar Structures.
Feng Q; Hong Y; Pradeep Nidamanuri N; Yang C; Li Q; Dong M
Chemistry; 2020 Aug; 26(43):9449-9453. PubMed ID: 32167218
[TBL] [Abstract][Full Text] [Related]
3. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
4. HIV and Alzheimer's disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein.
Hategan A; Masliah E; Nath A
J Neurovirol; 2019 Oct; 25(5):648-660. PubMed ID: 31016584
[TBL] [Abstract][Full Text] [Related]
5. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
[TBL] [Abstract][Full Text] [Related]
6. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
[TBL] [Abstract][Full Text] [Related]
7. In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide.
Maderna E; Colombo L; Cagnotto A; Di Fede G; Indaco A; Tagliavini F; Salmona M; Giaccone G
Mol Neurobiol; 2018 Aug; 55(8):6834-6840. PubMed ID: 29349578
[TBL] [Abstract][Full Text] [Related]
8. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.
Pike CJ; Overman MJ; Cotman CW
J Biol Chem; 1995 Oct; 270(41):23895-8. PubMed ID: 7592576
[TBL] [Abstract][Full Text] [Related]
9. Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
Son G; Lee BI; Chung YJ; Park CB
Acta Biomater; 2018 Feb; 67():147-155. PubMed ID: 29221856
[TBL] [Abstract][Full Text] [Related]
10. Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production.
Chen X; Hui L; Geiger NH; Haughey NJ; Geiger JD
Neurobiol Aging; 2013 Oct; 34(10):2370-8. PubMed ID: 23673310
[TBL] [Abstract][Full Text] [Related]
11. Structure-neurotoxicity relationships of amyloid beta-protein oligomers.
Ono K; Condron MM; Teplow DB
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14745-50. PubMed ID: 19706468
[TBL] [Abstract][Full Text] [Related]
12. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6).
Kim JR; Murphy RM
Biophys J; 2004 May; 86(5):3194-203. PubMed ID: 15111432
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
[TBL] [Abstract][Full Text] [Related]
16. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo A; Yankner BA
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12243-7. PubMed ID: 7991613
[TBL] [Abstract][Full Text] [Related]
19. The new β amyloid-derived peptide Aβ1-6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity.
Diomede L; Romeo M; Cagnotto A; Rossi A; Beeg M; Stravalaci M; Tagliavini F; Di Fede G; Gobbi M; Salmona M
Neurobiol Dis; 2016 Apr; 88():75-84. PubMed ID: 26792398
[TBL] [Abstract][Full Text] [Related]
20. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
